124 related articles for article (PubMed ID: 21840612)
1. Assessment of tumor hypoxia and interstitial fluid pressure by gadomelitol-based dynamic contrast-enhanced magnetic resonance imaging.
Gulliksrud K; Hompland T; Galappathi K; Rofstad EK
Radiother Oncol; 2011 Oct; 101(1):217-22. PubMed ID: 21840612
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights.
Hompland T; Gulliksrud K; Ellingsen C; Rofstad EK
Acta Oncol; 2013 Apr; 52(3):627-35. PubMed ID: 23126523
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of Gd-DTPA and gadomelitol as contrast agents in DCE-MRI of cervical carcinoma interstitial fluid pressure.
Hompland T; Ellingsen C; Rofstad EK
BMC Cancer; 2012 Nov; 12():544. PubMed ID: 23173554
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure.
Gulliksrud K; Brurberg KG; Rofstad EK
Radiother Oncol; 2009 Apr; 91(1):107-13. PubMed ID: 18973959
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue of cervical carcinoma xenografts: associations with tumor hypoxia and interstitial fluid pressure and its assessment by DCE-MRI and DW-MRI.
Hompland T; Ellingsen C; Galappathi K; Rofstad EK
Acta Oncol; 2014 Jan; 53(1):6-15. PubMed ID: 23445339
[TBL] [Abstract][Full Text] [Related]
7. Interstitial fluid pressure and associated lymph node metastasis revealed in tumors by dynamic contrast-enhanced MRI.
Hompland T; Ellingsen C; Øvrebø KM; Rofstad EK
Cancer Res; 2012 Oct; 72(19):4899-908. PubMed ID: 23027087
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenografts.
Wegner CS; Hauge A; Gaustad JV; Andersen LMK; Simonsen TG; Galappathi K; Rofstad EK
Acta Oncol; 2017 Dec; 56(12):1754-1762. PubMed ID: 28661213
[TBL] [Abstract][Full Text] [Related]
9. Assessment of microvascular density, extracellular volume fraction, and radiobiological hypoxia in human melanoma xenografts by dynamic contrast-enhanced MRI.
Vestvik IK; Egeland TA; Gaustad JV; Mathiesen B; Rofstad EK
J Magn Reson Imaging; 2007 Oct; 26(4):1033-42. PubMed ID: 17896373
[TBL] [Abstract][Full Text] [Related]
10. Assessment of hypoxia and radiation response in intramuscular experimental tumors by dynamic contrast-enhanced magnetic resonance imaging.
Øvrebø KM; Hompland T; Mathiesen B; Rofstad EK
Radiother Oncol; 2012 Mar; 102(3):429-35. PubMed ID: 22197352
[TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of tumors: a preclinical study of cervical carcinoma and melanoma xenografts.
Øvrebø KM; Ellingsen C; Hompland T; Rofstad EK
Acta Oncol; 2013 Apr; 52(3):604-11. PubMed ID: 22671573
[TBL] [Abstract][Full Text] [Related]
12. Differentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging.
Gulliksrud K; Øvrebø KM; Mathiesen B; Rofstad EK
Radiother Oncol; 2011 Mar; 98(3):360-4. PubMed ID: 21262548
[TBL] [Abstract][Full Text] [Related]
13. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced-MRI of tumor hypoxia.
Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
Magn Reson Med; 2012 Feb; 67(2):519-30. PubMed ID: 21661044
[TBL] [Abstract][Full Text] [Related]
15. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
[TBL] [Abstract][Full Text] [Related]
16. DCE-MRI of patient-derived xenograft models of uterine cervix carcinoma: associations with parameters of the tumor microenvironment.
Hauge A; Wegner CS; Gaustad JV; Simonsen TG; Andersen LMK; Rofstad EK
J Transl Med; 2017 Nov; 15(1):225. PubMed ID: 29100521
[TBL] [Abstract][Full Text] [Related]
17. DCE-MRI of the hypoxic fraction, radioresponsiveness, and metastatic propensity of cervical carcinoma xenografts.
Ellingsen C; Hompland T; Galappathi K; Mathiesen B; Rofstad EK
Radiother Oncol; 2014 Feb; 110(2):335-41. PubMed ID: 24231244
[TBL] [Abstract][Full Text] [Related]
18. Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast-enhanced MRI.
Egeland TA; Gaustad JV; Vestvik IK; Benjaminsen IC; Mathiesen B; Rofstad EK
Magn Reson Med; 2006 Apr; 55(4):874-82. PubMed ID: 16506163
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images.
Egeland TA; Simonsen TG; Gaustad JV; Gulliksrud K; Ellingsen C; Rofstad EK
Radiat Res; 2009 Sep; 172(3):339-47. PubMed ID: 19708783
[TBL] [Abstract][Full Text] [Related]
20. Assessment of fraction of hypoxic cells in human tumor xenografts with necrotic regions by dynamic contrast-enhanced MRI.
Egeland TA; Gaustad JV; Benjaminsen IC; Hedalen K; Mathiesen B; Rofstad EK
Radiat Res; 2008 Jun; 169(6):689-99. PubMed ID: 18494552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
